Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cerebrospinal fluid analysis in the context of CNS demyelinating diseases.
Microglial Voltage-Gated Proton Channel Hv1 in Ischemic Stroke.
Multiple sclerosis in Isfahan, Iran: an update.
Does the six-minute walk test measure walking performance or physical fitness in persons with multiple sclerosis?
Lipopolysaccharide from Rhodobacter sphaeroides Attenuates Microglia-Mediated Inflammation and Phagocytosis and Directs Regulatory T Cell Response.
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS.
Cerebrospinal fluid oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald criteria 2010: Yes.
An ex-vivo multiple sclerosis model of inflammatory demyelination using hyperbranched polymer.
NADH-dehydrogenase Type-2 Suppresses Irreversible Visual Loss and Neurodegeneration in the EAE Animal Model of MS.
Walking Speed and Brain Glucose Uptake are Uncoupled in Patients with Multiple Sclerosis.
Long-term follow-up of immunotherapy-unresponsive recurrent tumefactive demyelination.
Use of Fingolimod in the Management of Relapsing-Remitting Multiple Sclerosis: Experience from Latin America.
Increased multiple sclerosis relapses related to lower prevalence of pain.
Neuroinflammation: no rose by any other name.
Erratum to: Anosmin-1 over-expression regulates oligodendrocyte precursor cell proliferation, migration and myelin sheath thickness.
OCT: New perspectives in neuro-ophthalmology.
Fingolimod effects on left ventricular function in multiple sclerosis.
Inhibition of System Xc- Transporter Attenuates Autoimmune Inflammatory Demyelination.
Autonomic Dysregulation in Multiple Sclerosis.
Recommendations for observational studies of comorbidity in multiple sclerosis.
Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.
Recessively transmitted predominantly motor neuropathies.
Support our campaign for better treatment for people with MS.
Longitudinally extensive transverse myelitis associated with amphiphysin autoimmunity and breast cancer: a paraneoplastic accompaniment.
Remyelination in multiple sclerosis: realizing a long-standing challenge.
Pages
« first
‹ previous
…
570
571
572
573
574
575
576
577
578
…
next ›
last »